LEKLI Announces that the National Agency for Medicines and Medical Devices, has granted the Marketing Authorization for Clobazam (ANTIKON L), ANTIKON L belongs to a group of medicines called benzodiazepines.
Clobazam works by having a calming effect on the brain.
ANTIKON L is used to treat severe anxiety over a short time, epilepsy (fits) over a longer time, mental illness such as schizophrenia (in combination with other treatments).
TIRANË—Dec 01, 2024—LEKLI shpk. announced that the National Agency for Medicines and Medical Devices has validated the Marketing Authorization Application (MAA) for Clobazam (ANTIKON L). The submission was supported by previously disclosed positive results of several years of work to achieve this vital formula.
